No services found
No Products found
Isatuximab is a humanized monoclonal antibody derived from IgG1 that targets CD38, a glycoprotein found on the surface of some immune cells. CD38 is highly expressed by malignant plasma cells in multiple myeloma. Isatuximab is used to treat multiple myeloma. It is marketed under the trade name Sarclisa.
There are no reviews yet.
Your email address will not be published. Required fields are marked *
In which application did you use the antibody? *
Did it work in your application? *
Your review *
Save my name, email, and website in this browser for the next time I comment.
Send us a message from the form below
Lab / Company
Your cart is currently empty.